APA (7th ed.) Citation

Vall-Sagarra, A., Litau, S., Decristoforo, C., Wängler, B., Schirrmacher, R., Fricker, G., & Wängler, C. (2018). Design, synthesis, in vitro, and initial in vivo evaluation of heterobivalent peptidic ligands targeting both NPY(Y1)- and GRP-receptors: An improvement for breast cancer imaging? Pharmaceuticals, 11(3), . https://doi.org/10.3390/ph11030065

Chicago Style (17th ed.) Citation

Vall-Sagarra, Alicia, Shanna Litau, Clemens Decristoforo, Björn Wängler, Ralf Schirrmacher, Gert Fricker, and Carmen Wängler. "Design, Synthesis, in Vitro, and Initial in Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y1)- and GRP-receptors: An Improvement for Breast Cancer Imaging?" Pharmaceuticals 11, no. 3 (2018). https://doi.org/10.3390/ph11030065.

MLA (9th ed.) Citation

Vall-Sagarra, Alicia, et al. "Design, Synthesis, in Vitro, and Initial in Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y1)- and GRP-receptors: An Improvement for Breast Cancer Imaging?" Pharmaceuticals, vol. 11, no. 3, 2018, https://doi.org/10.3390/ph11030065.